Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
Pevonedistat
NAE1
NAE1
11057.135
uM
1.28990
0.96672
0.1560 0.1358 1.0990 0.2860
0.9973
3.9340
SUM159PT
TNBC
Basal B
Nelfinavir
13054.174
uM
inf
inf
0.9613 0.9613 0.0000 0.0251
0.1450
3.1161
SUM159PT
TNBC
Basal B
Nelfinavir
13004.174
uM
9.96910
15.89760
-0.7031 -1.0000 2.3541 0.1857
0.9862
3.2757
SUM159PT
TNBC
Basal B
Nilotinib
ABL
nRTK
11057.145
uM
inf
inf
1.0062 1.0062 0.0000 -0.0143
-0.1841
3.8266
SUM159PT
TNBC
Basal B
NSC 663284
CDC25
CDC
10520.14
uM
1.48650
1.72640
-0.7051 -0.5565 5.0000 0.5214
0.9692
3.7031
SUM159PT
TNBC
Basal B
NSC 663284
CDC25
CDC
11057.152
uM
2.59470
3.4840
-0.7348 -0.5153 2.4037 0.4415
0.9745
3.8541
SUM159PT
TNBC
Basal B
NU6102
CDK1/2
CDK
11057.147
uM
17.1090
24.21920
-0.1545 -0.3781 1.6205 0.1481
0.9919
3.9818
SUM159PT
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
7531.066
uM
28.51480
18.95280
0.4313 0.4300 4.8127 0.0341
0.9860
3.3129
SUM159PT
TNBC
Basal B
Olomoucine II
CDK1
CDK
11057.147
uM
7.28880
6.97660
0.0532 0.0438 2.0939 0.2366
0.9949
3.9818
SUM159PT
TNBC
Basal B
Omipalisib
PI3K
PI3K
10520.087
uM
0.05981
0.06791
-0.1654 -0.1232 1.7340 0.5120
0.9904
2.3483
SUM159PT
TNBC
Basal B
Omipalisib
PI3K
PI3K
7531.086
uM
0.02036
0.02017
-0.0133 0.0051 1.1296 0.5707
0.9982
3.3103
SUM159PT
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7920.075
uM
9.39680
19.30080
-0.2022 -0.3465 0.7314 0.3790
0.9828
4.5785
SUM159PT
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
9844.021
uM
3.94970
11.04590
-0.5941 -0.6389 0.8005 0.4951
0.9919
2.4889
SUM159PT
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7919.011
uM
3.12240
8.27220
-0.4592 -0.5231 0.7349 0.5067
0.9950
3.6508
SUM159PT
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7918.011
uM
3.87110
9.76440
-0.4701 -0.5380 0.7894 0.5014
0.9983
2.8897
SUM159PT
TNBC
Basal B
Oxamflatin
HDAC
HDAC
11057.147
uM
0.84250
4.57980
-0.7232 -1.0000 0.6489 0.4577
0.9988
3.9818
SUM159PT
TNBC
Basal B
PD 98059
MEK
MAPK
11057.152
uM
172.25410
634.23160
0.7857 -0.9988 0.8422 0.0305
0.8640
3.8541
SUM159PT
TNBC
Basal B
PD 98059
MEK
MAPK
10520.136
uM
inf
60.9410
0.7037 0.5045 0.8153 0.0356
0.8909
4.0331
SUM159PT
TNBC
Basal B
PD173074
FGFR1/3
RTK
7531.093
uM
7.4930
12.79190
-0.7611 -1.0000 2.0541 0.1933
0.9948
3.5995
SUM159PT
TNBC
Basal B
PD173074
FGFR1/3
RTK
10520.1
uM
10.6390
15.90380
-0.7137 -0.7746 2.3277 0.1919
0.9963
3.6151
SUM159PT
TNBC
Basal B
PD184352
MEK
MAPK
11057.155
uM
20.13750
999.99970
0.4189 -0.5412 0.1878 0.2397
0.9353
4.1614
SUM159PT
TNBC
Basal B
PD184352
MEK
MAPK
11057.155
uM
20.13750
999.99970
0.4189 -0.5412 0.1878 0.2397
0.9353
4.1614
SUM159PT
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7531.095
uM
inf
inf
0.9518 0.9518 0.0000 0.0484
0.3294
3.5302
SUM159PT
TNBC
Basal B
PS-1145
IKK
NFKB
7531.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0370
-7.5867
3.4461
SUM159PT
TNBC
Basal B
Purvalanol A
CDK1
CDK
7531.067
uM
inf
34.52310
0.8619 0.8619 5.0000 0.0137
0.8457
3.6061